Concord Biotech Limited (CONCORDBIO.NS)

INR 1490.6

(-1.84%)

Total Liabilities Summary of Concord Biotech Limited

  • Concord Biotech Limited's latest annual total liabilities in 2023 was 1.74 Billion INR , down -22.29% from previous year.
  • Concord Biotech Limited's latest quarterly total liabilities in 2024 Q1 was -15.26 Billion INR , down -977.06% from previous quarter.
  • Concord Biotech Limited reported annual total liabilities of 2.23 Billion INR in 2022, up 6.88% from previous year.
  • Concord Biotech Limited reported annual total liabilities of 2.09 Billion INR in 2021, up 14.41% from previous year.
  • Concord Biotech Limited reported quarterly total liabilities of 1.74 Billion INR for 2023 Q4, down 0.0% from previous quarter.
  • Concord Biotech Limited reported quarterly total liabilities of 1.74 Billion INR for 2023 FY, down -22.29% from previous quarter.

Annual Total Liabilities Chart of Concord Biotech Limited (2023 - 2019)

Historical Annual Total Liabilities of Concord Biotech Limited (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 1.74 Billion INR -22.29%
2022 2.23 Billion INR 6.88%
2021 2.09 Billion INR 14.41%
2020 1.83 Billion INR 7.57%
2019 1.7 Billion INR 0.0%

Peer Total Liabilities Comparison of Concord Biotech Limited

Name Total Liabilities Total Liabilities Difference
Biocon Limited 307.95 Billion INR 99.435%
Blue Jet Healthcare Limited 2.13 Billion INR 18.519%
Dishman Carbogen Amcis Limited 39.53 Billion INR 95.598%
Jubilant Ingrevia Limited 19.94 Billion INR 91.273%
Lyka Labs Limited 884.58 Million INR -96.773%
Panacea Biotec Limited 4.02 Billion INR 56.703%
Piramal Pharma Limited 74 Billion INR 97.648%
SMS Lifesciences India Limited 1.96 Billion INR 11.591%
Supriya Lifescience Limited 1.05 Billion INR -64.412%
Syngene International Limited 18.93 Billion INR 90.809%
TAKE Solutions Limited 969.78 Million INR -79.487%
Zota Health Care Limited 1.38 Billion INR -25.812%